{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:29:34Z","timestamp":1761182974584,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/s10156-012-0545-x","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T13:11:43Z","timestamp":1358341903000},"page":"691-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Takuya","family":"Kotani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Wakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-012-0545-x_bib0005","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/ard.60.12.1141","article-title":"Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus","volume":"60","author":"No\u00ebl","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0010","first-page":"75","article-title":"Efficacy of anti-\u03b2-glucan antibody in early diagnosis and treatment of opportunistic infections on immunosuppressive therapy in ANCA associated vasculitis","volume":"31","author":"Yoshida","year":"2004","journal-title":"Rheumatology (Tokyo)"},{"key":"10.1007\/s10156-012-0545-x_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3314\/jjmm.34.311","article-title":"Clinical aspects of deep mycosis in patients with collagen diseases","volume":"34","author":"Hirano","year":"1993","journal-title":"Jpn J Med Mycol"},{"key":"10.1007\/s10156-012-0545-x_bib0020","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/JCM.39.3.954-958.2001","article-title":"In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi","volume":"39","author":"Espinel-Ingroff","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-012-0545-x_bib0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s100960000334","article-title":"In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens","volume":"19","author":"Quind\u00f3s","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","article-title":"AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience","volume":"49","author":"Adler-Moore","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-012-0545-x_bib0035","first-page":"S3","article-title":"AmBisome targeting to fungal infections","volume":"14","author":"Adler-Moore","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1007\/s10156-012-0545-x_bib0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0050","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0055","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10156-009-0689-5","article-title":"Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm","volume":"15","author":"Aikawa","year":"2009","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-012-0545-x_bib0070","first-page":"980","article-title":"Case of pulmonary cryptococcosis which developed in a patient receiving abatacept therapy for rheumatoid arthritis","volume":"48","author":"Karino","year":"2010","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1007\/s10156-012-0545-x_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2336\/nishinihonhifu.66.29","article-title":"A case of cutaneous cryptococcosis associated with rheumatoid arthritis","volume":"66","author":"Abe","year":"2004","journal-title":"Nishinihon Hifuka"},{"key":"10.1007\/s10156-012-0545-x_bib0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s10067-006-0319-x","article-title":"Bilateral spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules, secondary infected by Aspergillus","volume":"26","author":"Winne","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1007\/s10156-012-0545-x_bib0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1471-2334-10-239","article-title":"Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report","volume":"10","author":"Probst","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0090","first-page":"1561","article-title":"Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab","volume":"29","author":"True","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1007\/s10156-012-0545-x_bib0095","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00134-003-1867-z","article-title":"Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate","volume":"29","author":"van der Klooster","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1007\/s10156-012-0545-x_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10156-008-0617-0","article-title":"An asymptomatic case of pulmonary cryptococcosis with endobronchial polypoid lesions and bilateral infiltrative shadow","volume":"14","author":"Shimizu","year":"2008","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-012-0545-x_bib0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1439-0507.2000.00563.x","article-title":"Case report. Primary cutaneous histoplasmosis in an immunosuppressed patient","volume":"43","author":"Romano","year":"2000","journal-title":"Mycoses"},{"key":"10.1007\/s10156-012-0545-x_bib0110","first-page":"53","article-title":"Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab","volume":"7","author":"Wilson","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1007\/s10156-012-0545-x_bib0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10096-004-1185-6","article-title":"Cavitating pneumonia after treatment with infliximab and prednisone","volume":"23","author":"Arend","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/s10165-006-0493-3","article-title":"Infectious myositis involving the piriformis in a patient with rheumatoid arthritis","volume":"16","author":"Oda","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1007\/s10156-012-0545-x_bib0125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/jcp.2004.016287","article-title":"Candida albicans peritonitis in a patient with Felty\u2019s syndrome","volume":"58","author":"Thomas","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1007\/s10156-012-0545-x_bib0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.20001","article-title":"A 21-year-old man with Still\u2019s disease with fever, rash, and pancytopenia","volume":"62","author":"Mehta","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1007\/s10156-012-0545-x_bib0135","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0545-x_bib0140","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13701004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13701004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10156-012-0545-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:51:39Z","timestamp":1761159099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X13701004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1341321X13701004"],"URL":"https:\/\/doi.org\/10.1007\/s10156-012-0545-x","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-012-0545-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}